Objectives

After participating in this educational activity, attendees should be able to:
1. Identify two predictors of long-term remission for pediatric anxiety disorders
2. Report the percent of anxious youth who remain chronically ill after treatment
 

Faculty

Golda Ginsburg, MD
Professor of Psychiatry
UCONN School of Medicine

 

Faculty Disclosure
Shannon Kay, PH.D., BCBA-D is a stock shareholder in Allergan, Pfizer, Glaxosmithklein, Merck, Gilead.

Session date: 
Tuesday, June 4, 2019 - 8:00am to 9:00am
Location: 
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.